The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
This strategic investment strengthens Cohance's integrated oligonucleotide platform
NorUDCA is the first?in?class treatment for Non?alcoholic Fatty Liver Disease (NAFLD) in India
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Vasograin Plus represents a major advancement in the treatment of migraine
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
Subscribe To Our Newsletter & Stay Updated
